Investigating use of convalescent plasma to treat COVID-19
SARNIA & PETROLIA – November 12, 2020 – Bluewater Health is pleased to confirm participation in a nationwide COVID-19 treatment study. The Convalescent Plasma for COVID-19 Research (CONCOR) trial is a collaboration between the Canadian Transfusion Research Network, the McMaster Centre for Transfusion Research, Canadian Blood Services, Héma-Québec and academic partners across Canada.
“Bluewater Health is pleased to be accepted as one of the clinical investigation sites for this Canadian COVID-19 trial,” says Dr. Mike Haddad, Chief of Staff, Bluewater Health. “Participating in a study of this calibre is a testament to our local skill set. We hope that our contribution, along with the other centres, would illuminate any potential benefit of this therapy in hospitalized COVID-19 patients.”
This study is designed to assess the safety and effectiveness of administering convalescent plasma collected from donors who have recovered from COVID-19, to patients admitted to hospital with COVID-19, to decrease the risk of serious disease and prevent death. More than 40 hospitals across the country will participate in this national study.
Convalescent plasma is the plasma of patients who have recovered from a virus, which generally means they have developed the antibodies necessary to fight off that virus. These antibodies develop in the body’s plasma to help protect against future infection from the same virus. Plasma is the liquid component of blood that contains the antibodies produced by patients who have recovered from COVID-19 disease.
Trial participants must be over 16 years of age, requiring oxygen, have been sick for less than 12 days, and their plasma must be compatible with donor plasma. Patients’ eligibility will be determined by the physician providing their in-hospital care and the research team. If selected, patients will be randomly assigned by the study’s research assistant to receive convalescent plasma or standard care, at a ratio of 2:1.
Bluewater Health, with locations in Sarnia and Petrolia, cares for the residents of Sarnia-Lambton. With close to 2,500 staff, Professional Staff and volunteers, Bluewater Health provides an array of specialized acute, complex continuing care, allied health and ambulatory care services. Bluewater Health’s Mission is: We create exemplary healthcare experiences with patients and families every time. For more information about Bluewater Health, visit www.bluewaterhealth.ca or follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Media, for more information contact:
Chief, Communications & Public Affairs